dr. arkenau on dabrafenib combined with trametinib for braf-mutated melanoma
Published 9 years ago • 168 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
0:59
the success of the dabrafenib and trametinib combination in braf-mutated melanoma
-
2:11
dr. georgina long on dabrafenib and trametinib in braf-mutated melanoma
-
1:52
dr. long on dabrafenib/trametinib in braf v600e-mutant melanoma
-
1:31
dr. daud on dabrafenib/trametinib vs immunotherapy in melanoma
-
1:08
fda approval of adjuvant dabrafenib/trametinib in braf melanoma
-
1:26
dr. nathan on long-term outcomes with dabrafenib/trametinib in braf v600-mutant melanoma
-
1:11
dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
0:48
dr. michael rotkowitz on the dabrafenib plus trametinib combination for melanoma
-
2:51
combi-ad: long-term follow-up of dabrafenib and trametinib in braf-mutated melanoma
-
0:53
dabrafenib plus trametinib demonstrates benefit in braf-mutant melanoma
-
2:19
dr. robert on 5-year analysis of dabrafenib/trametinib in braf v600-mutant melanoma
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma
-
0:44
dr. michael rotkowitz on dabrafenib and trametinib combination side effects
-
2:12
phase iii combi-d study of dabrafenib and trametinib in patients with melanoma
-
3:05
dabrafenib and trametinib: a promising combination for the treatment of melanoma
-
2:46
long-term outcomes with dabrafenib plus trametinib in braf v600-mutant melanoma
-
1:24
adverse events with dabrafenib/trametinib combination in melanoma
-
2:33
dr. sullivan discusses role of dabrafenib plus trametinib in melanoma